Your browser does not support scripts, this page will not display properly!
ISMP (US)
Contact Us
Feedback
Search:
ISMP Canada News
February 14, 2018:
Health Canada: Tecentriq (atezolizumab) - Risk of Myocarditis
Health Canada: Tecentriq (atezolizumab) - Risk of Myocarditis" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/320/" />
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.